Pfizer
More News
-
Pfizer withdraws sickle cell disease treatment from global markets
Data indicates that risks associated with OXBRYTA include higher incidence of vaso-occlusive crises and fatal events
-
Pfizer revives weight-loss drug
Pfizer plans clinical trials for a once-daily weight-loss pill, danuglipron, after scrapping twice-daily version
-
Moderna sues Pfizer/BioNTech for patent infringement over Covid vaccine
Moderna alleges Pfizer/BioNTech copied mRNA technology that it had patented between 2010 and 2016
-
Britain approves Pfizer's antiviral Covid-19 pill
Britain is scrambling to build its defences amid a record surge in Covid-19 cases in the winter season
-
Christmas gift: US donates 5m doses of Pfizer vaccine to Pakistan
Getting vaccinated is the best gift you can give to your loved ones this holiday season, says US chargé d’affaires
-
Pfizer-BioNTech 33% effective against Omicron strain: study
2 doses of vaccine reduce hospitalisations due to Omicron by 70%, says research by South African health insurance
-
Pfizer signs $5.3 billion US deal to supply Covid-19 antiviral pills
The drugmaker applied for emergency authorisation of the drug, branded as Paxlovid, this week
-
Pfizer says antiviral pill cuts risk of severe Covid-19 by 89%
Planned analysis of 1,219 patients looked at hospitalisations or deaths among people diagnosed with coronavirus
-
Pfizer begins study of oral drug for prevention of Covid-19
The drugmaker has been racing to develop an easy-to-administer antiviral pill for Covid-19
-
Vaccination drive expanded to 15-year-olds
Forum says NADRA’s Form B will be required for registration purpose
1727333640-0/BeFunk_§_-(62)1727333640-0.jpg "pfizer withdraws sickle cell disease treatment from global markets")
